| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88f04349dc03f2df3dbd83ba54beb514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf0f68bc9b66c444a1b7b970ce248f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ff1f7b19292c59f3e5a4d1afb638e1d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ace2a5a9c8bc07f0f54f20f8aac9b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd7eea5f58a2470a041327a9ff634fc |
| publicationDate |
2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004112691-A2 |
| titleOfInvention |
Interferon gamma therapies for idiopathic pulmonary fibrosis |
| abstract |
The present invention provides methods of treating idiopathic pulmonary fibrosis (IPF); methods of increasing survival time in an individual with IPF; and methods of reducing risk of death in an individual with IPF. The methods generally involve administering a therapeutically effective amount of IFN-Ϝ to an individual with IPF. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105571-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105572-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8110181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2494982-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1940451-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103550757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005336519-B2 |
| priorityDate |
2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |